Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandra Gonzalez-Duarte

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Annals of Clinical and Translational Neurology|August 10, 2022
Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stagesRoy Freeman, Alejandra Gonzalez-Duarte, Fabio Barroso, et al.
Glia|September 4, 2024
Neuronal and glial cell alterations involved in the retinal degeneration of the familial dysautonomia optic neuropathyAnastasia Schultz, Henar Albertos-Arranz, Xavier Sánchez Sáez, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 24, 2024
Carotid baroreceptor dysfunction after carotid body tumour resectionsSantiago Mier Y Teran-Ellis, Luis O Bobadilla-Rosado, Javier E Anaya-Ayala, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 15, 2026
Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extensionCécile Cauquil, David Adams, Julian Gillmore, et al.
Vascular|November 17, 2022
Physiological and clinical impact in the carotid baroreceptor function following the surgical management of bilateral carotid body tumorsSantiago Mier Y Teran-Ellis, Humberto A Estrada-Rodriguez, Javier E Anaya-Ayala, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 7, 2025
Autonomic dysfunction and quality of life in a cohort of neurology outpatients with post-acute sequelae of COVID-19, a two-year follow-up studySamarah Ahmed, Julia Greenberg, Rachel Kenney, et al.
Orphanet Journal of Rare Diseases|November 10, 2023
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)Luca Gentile, Teresa Coelho, Angela Dispenzieri, et al.
Nucleic Acids Research|June 2, 2026
Addressing the needs of nano-rare patients: the n-Lorem experienceStanley T Crooke, Sarah Glass, Joseph G Gleeson, et al.
JAMA|March 20, 2024
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With SynucleinopathiesChristopher H Gibbons, Todd Levine, Charles Adler, et al.
Annals of Clinical and Translational Neurology|December 26, 2025
Cutaneous Phosphorylated Alpha-Synuclein in Lewy Body DementiaChristopher H Gibbons, Todd Levine, Charles H Adler, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Annals of Clinical and Translational Neurology|August 10, 2022
Cutaneous amyloid is a biomarker in early ATTRv neuropathy and progresses across disease stagesRoy Freeman, Alejandra Gonzalez-Duarte, Fabio Barroso, et al.
Glia|September 4, 2024
Neuronal and glial cell alterations involved in the retinal degeneration of the familial dysautonomia optic neuropathyAnastasia Schultz, Henar Albertos-Arranz, Xavier Sánchez Sáez, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 24, 2024
Carotid baroreceptor dysfunction after carotid body tumour resectionsSantiago Mier Y Teran-Ellis, Luis O Bobadilla-Rosado, Javier E Anaya-Ayala, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 15, 2026
Long-term efficacy and safety of vutrisiran in hereditary transthyretin amyloidosis with polyneuropathy: final analysis of the HELIOS-A randomized treatment extensionCécile Cauquil, David Adams, Julian Gillmore, et al.
Vascular|November 17, 2022
Physiological and clinical impact in the carotid baroreceptor function following the surgical management of bilateral carotid body tumorsSantiago Mier Y Teran-Ellis, Humberto A Estrada-Rodriguez, Javier E Anaya-Ayala, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 7, 2025
Autonomic dysfunction and quality of life in a cohort of neurology outpatients with post-acute sequelae of COVID-19, a two-year follow-up studySamarah Ahmed, Julia Greenberg, Rachel Kenney, et al.
Orphanet Journal of Rare Diseases|November 10, 2023
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)Luca Gentile, Teresa Coelho, Angela Dispenzieri, et al.
Nucleic Acids Research|June 2, 2026
Addressing the needs of nano-rare patients: the n-Lorem experienceStanley T Crooke, Sarah Glass, Joseph G Gleeson, et al.
JAMA|March 20, 2024
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With SynucleinopathiesChristopher H Gibbons, Todd Levine, Charles Adler, et al.
Annals of Clinical and Translational Neurology|December 26, 2025
Cutaneous Phosphorylated Alpha-Synuclein in Lewy Body DementiaChristopher H Gibbons, Todd Levine, Charles H Adler, et al.
Pageof 4